Efficacy and safety of oral strontium ranelate for the treatment of knee osteoarthritis: rationale and design of randomised, double-blind, placebo-controlled trial
Objective: The osteoporosis drug strontium ranelate dissociates bone remodelling processes. It also inhibits subchondral bone resorption and stimulates cartilage matrix formation in vitro. Exploratory studies in the osteoporosis trialsreport that strontium ranelate reduces biomarkers of cartilage de...
Main Authors: | Cyrus Cooper, J-Y Reginster, R Chapurlat, C Christiansen, H Genant, N Bellamy, W Bensen, F Navarro, J Badurski, E Nasonov, X Chevalier, P N Sambrook |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IMA PRESS LLC
2013-12-01
|
Series: | Научно-практическая ревматология |
Subjects: | |
Online Access: | https://rsp.mediar-press.net/rsp/article/view/1333 |
Similar Items
-
Osteoarthrosis: An old disease, novel approaches
by: Aleksandr Ivanovich Dubikov
Published: (2013-06-01) -
Strontium ranelate is a drug to treat osteoarthrosis
by: Oksana Anatolyevna Nikitinskaya
Published: (2013-03-01) -
Pathogenetic treatment with strontium ranelate in women with postmenopausal osteoporosis
by: Olga Borisovna Yershova
Published: (2010-12-01) -
STRONTIUM RANELATE IS THE DRUG OF CHOICE IN THE TREATMENT OF OSTEOPOROSIS
by: Nataliya Vladimirovna Toroptsova
Published: (2010-09-01) -
PLEIOTROPIC EFFECTS OF THE BONE METABOLISM MODULATOR - STRONTIUM RANELATE IN TREATMENT OF WOMEN WITH THE POSTMENOPAUSAL OSTEOPOROSIS AND ARTERIAL HYPERTENSION.
by: N. Yu. Khozyainova, et al.
Published: (2010-04-01)